title: Clinical research regulation in India-history, development, initiatives, challenges and controversies: Still long way to go.
abstract: The Central Drugs Standard Control Organisation and its chairman Drug Controller general of India are bequeathed to protect the citizens from the marketing of unsafe medication. The startling findings, of the 59(th)report of the Parliamentary Standing Committee on Health and Family Welfare, have uncovered the lax standards followed by the regulatory authorities in India. The growing clinical research after the product patents rights for the pharmaceutical industries as per the trade related aspects of intellectual property rights agreement and adverse drug reaction monitoring of the marketed drugs have raised many ethical and regulatory issues regarding the promotion of new drugs in Indian markets. Many controversial group of medicines; unauthorised and irrational FDCs not relevant to India's medical needs, are available which are not sold in any of the countries with matured regulatory bodies. It becomes vital to understand the history, growth and evolution of the regulatory aspects of drugs which are handled by multiple Ministries and Departments of the Government of India. Although amendment to Schedule Y, registration of Contract Research Organisations, registration of Clinical Trials, Speeding up review process, Pharmacovigilance (PhV) programme for India and Inspection of clinical trial sites have been started by the various regulatory agencies. However due to casual approach in marketing approval for sale of the drugs, the unethical steps taken by some pharmaceutical companies and medical practitioners has reiterated the need to get appropriate understanding of present regulation of drugs and clinical research especially regarding the practical rules and regulations.
authors.affiliation: Department of Pharmacology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard, New Delhi, India.
authors.forename: Mohammed
authors.initials: M
authors.lastname: Imran
authors.forename: Abul K
authors.initials: AK
authors.lastname: Najmi
authors.forename: Mohammad F
authors.initials: MF
authors.lastname: Rashid
authors.forename: Shams
authors.initials: S
authors.lastname: Tabrez
authors.forename: Mushtaq A
authors.initials: MA
authors.lastname: Shah
keywords: CDSCO; clinical research; drug and cosmetic act; drug and cosmetic rule; drug regulation
references.citation: Ann Pediatr Cardiol. 2008 Jul;1(2):81-2
references.pmid: 20300247
references.citation: Natl Med J India. 2008 Jan-Feb;21(1):31-4
references.pmid: 18472701
references.citation: Perspect Clin Res. 2011 Apr;2(2):45-7
references.pmid: 21731852
references.citation: Pharmazie. 2008 Apr;63(4):251-5
references.pmid: 18468382
references.citation: Natl Med J India. 1995 Jan-Feb;8(1):1-3
references.pmid: 7696937
references.citation: J Adv Pharm Technol Res. 2011 Apr;2(2):88-93
references.pmid: 22171299
references.citation: Br J Clin Pharmacol. 2003 Jan;55(1):1-5
references.pmid: 12534634
references.citation: Perspect Clin Res. 2010 Oct;1(4):139-42
references.pmid: 21350729
references.citation: Perspect Clin Res. 2011 Jan;2(1):28-33
references.pmid: 21584179
references.citation: Indian J Med Ethics. 2012 Jul-Sep;9(3):207-9
references.pmid: 22864084
references.citation: Perspect Clin Res. 2010 Jan;1(1):25-8
references.pmid: 21829778
references.citation: Indian J Pharm Sci. 2008 Sep;70(5):547-54
references.pmid: 21394248
references.citation: EMBO Rep. 2011 Feb;12(2):110-2
references.pmid: 21283115
references.citation: J Postgrad Med. 2001 Jan-Mar;47(1):45-50
references.pmid: 11590294
references.citation: J Pharm Biomed Anal. 2008 Jan 7;46(1):18-29
references.pmid: 18037599
references.citation: N Engl J Med. 2005 Apr 21;352(16):1633-6
references.pmid: 15843665
references.citation: Perspect Clin Res. 2012 Jan;3(1):1-3
references.pmid: 22347694
references.citation: J Clin Pathol. 2006 Apr;59(4):335-9
references.pmid: 16567467
references.citation: J Postgrad Med. 2008 Oct-Dec;54(4):318-23
references.pmid: 18953154
references.citation: Bull World Health Organ. 2008 Aug;86(8):581-2
references.pmid: 18797610
references.citation: Pharmacol Res. 2007 Jul;56(1):1-10
references.pmid: 17391981